Deepbridge Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Elasmogenelasmogen.comJan 2026
soloMER anti-inflammatory drug designed to be delivered to specific sites in the body.
Aberdeen, GB
Professor Caroline Barelle MBA(Founder & Chief Executive Officer)Professor Andy Porter FRSB, FRSE(Co-founder & Chief Technical Officer)Dr Obinna Ubah(Founding member; Autoimmunity/Immunology Lead)
Co-investorsScottish National Investment BankInnovate UKScottish EnterpriseScottish Investment Bank
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.